Retained Products of Conception Clinical Trial
Official title:
Predictive Factors for Successful Operative Hysteroscopy Using Tissue Removal Device (TruClear System) Without Anesthesia
NCT number | NCT05722028 |
Other study ID # | 123456 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | August 1, 2022 |
Est. completion date | August 31, 2023 |
Background: Small-diameter operative hysteroscopes may allow to perform operative hysteroscopy without general anesthesia in selected patients. One of these instruments is the tissue removal device (TRD), which resects and removes intrauterine pathology such as endometrial polyps and retained products of conception (RPOC) with a diameter of ¬6 mm. Objective: To assess the success rate and intraoperative pain of patients undergoing operative hysteroscopy without anesthesia with the TRD (TruClear Elite Mini-Hysteroscope) for removal of endometrial polyps or RPOC. Methods: Prospective observational study. Participation in the study was offered to patients diagnosed with uterine polyps or RPOC on office diagnostic hysteroscopy. The patients filled out a digital questionnaire before and after the operation. A successful procedure was defined as complete hysteroscopic removal of the uterine pathology using the TruClear system. Oral 400 mcg misoprostol 12 hours before the procedure was prescribed for cervical ripening.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | August 31, 2023 |
Est. primary completion date | August 31, 2023 |
Accepts healthy volunteers | |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Diagnosis of polyp or retained products of conception in diagnostic hysteroscopy. - Medical need to remove the finding according to accepted criteria. - Patient's consent to the removal of the finding in a procedure without anesthesia. - Patient's consent to participate in the study. Exclusion Criteria: - Any indication for performing the procedure under anesthesia in an operating room, such as: 1. Medical background requiring operation in an operating room. 2. Personal / mental background requiring procedure under general anesthesia. 3. Cervical stenosis 4. Previous failure to remove the finding in a procedure without anesthesia 5. Lack of response to performing the operation without anesthesia - The lack of response to participate in the study - A known diagnosis of malignancy from a previous sample of the polyp or endometrium |
Country | Name | City | State |
---|---|---|---|
Israel | Shamir medical center | Zrifin |
Lead Sponsor | Collaborator |
---|---|
Assaf-Harofeh Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Procedure completed successfully | Was the procedure completed - yes/no | Immediately after procedure | |
Secondary | Prevalence of VAS (pain scale) > 5 during procedure | VAS (Visual analogue scale 0-10, most painful 10) grading by the patient | Immediately after procedure | |
Secondary | Prevalence of VAS (pain scale) > 5, five minutes after procedure | VAS (Visual analogue scale 0-10, most painful 10) grading by the patient | 5 minutes after procedure | |
Secondary | Acceptable procedure by the patient | Was the procedure acceptable by the patient (1-4 when 1 is most acceptable) | 5 minutes after procedure | |
Secondary | Recommended procedure by the patient | Would the patient recommend her acquittance the procedure in this outline (1-5, most recommended 5) aquitance (1-5) | 5 minutes after procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05811286 -
The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study
|
N/A | |
Recruiting |
NCT04804332 -
Removal of Intrauterine Retained Products of Conception (RPOC) After Miscarriage Guided by Hysteroscopy Trial. A Randomized Controlled Trial.
|
N/A | |
Recruiting |
NCT04637373 -
Hysteroscopy Assisted Suction Curettage for Early Pregnancy Loss
|
N/A | |
Recruiting |
NCT04705324 -
Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion
|
N/A | |
Recruiting |
NCT06009679 -
MISOPROSTOL FOR THE TREATMENT OF SUSPECTED POSTPARTUM RETAINED PRODUCTS OF CONCEPTION
|
N/A | |
Completed |
NCT04917016 -
B-HCG Levels in Women Diagnosed With Retained Products of Conception
|
||
Recruiting |
NCT05085067 -
The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception
|
N/A | |
Active, not recruiting |
NCT03880435 -
HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant
|
N/A |